Neuro Industry develops large foundation models trained on brainwave data to enhance mental health care, focusing on applications in drug development and personalized treatment. Their technology provides clinicians and researchers with precise insights into brain activity, improving treatment outcomes and accelerating research processes.
Funding
Funding not disclosed
Founders
Product
Problem
Mental healthcare providers and researchers lack precise tools for analyzing brainwave data, hindering advancements in drug development and personalized treatment strategies. Traditional methods often struggle with data complexity and noise, limiting the ability to extract meaningful insights from EEG recordings.
Solution
Neuro Industry offers a suite of AI-powered tools designed to analyze and interpret brainwave data, facilitating advancements in mental health treatment and research. Their large cognition models, trained on extensive brainwave datasets, enable precise insights into brain activity. The platform provides clinicians and researchers with advanced capabilities for EEG processing, data management, and the development of personalized treatment plans. By leveraging AI, Neuro Industry aims to improve treatment outcomes, accelerate research processes, and enhance the overall efficacy of mental healthcare interventions.
Target Audience
The primary users are clinicians, researchers, and healthcare companies involved in mental health, drug development, and neuroscience research.
Features
- Large cognition models trained on extensive brainwave datasets for accurate analysis.
- EEG processing toolset utilizing state-of-the-art pre-processing and de-noising techniques.
- Data platform for secure storage and management of brainwave and health record data.
- Tools for fine-tuning models for various downstream applications in psychiatry and neuroscience.
- Capabilities for developing personalized treatment plans based on individual brainwave patterns.